Cita APA

Nieto, L. P., Caballero, R. F., Sánchez-Hernández, J., Rebollo, N., Pérez, M. P., González, D. G., . . . López, M. O. (2018). 4CPS-157 Vedolizumab: Early experience and medium-term outcomes in inflammatory bowel disease. Eur J Hosp Pharm.

Citación estilo Chicago

Nieto, L Pedraza, R Fernández Caballero, JG Sánchez-Hernández, N. Rebollo, MC Piñero Pérez, D García González, EM Sáez Fernández, y MJ Otero López. "4CPS-157 Vedolizumab: Early Experience and Medium-term Outcomes in Inflammatory Bowel Disease." Eur J Hosp Pharm 2018.

Cita MLA

Nieto, L Pedraza, et al. "4CPS-157 Vedolizumab: Early Experience and Medium-term Outcomes in Inflammatory Bowel Disease." Eur J Hosp Pharm 2018.